Annual CAPEX
$280.00 K
-$93.00 K-24.93%
01 June 2022
Summary:
Pluristem Therapeutics annual capital expenditures is currently $280.00 thousand, with the most recent change of -$93.00 thousand (-24.93%) on 01 June 2022. During the last 3 years, it has fallen by -$93.00 thousand (-24.93%).PSTI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$73.00 K
-$126.00 K-63.32%
01 September 2022
Summary:
Pluristem Therapeutics quarterly capital expenditures is currently $73.00 thousand, with the most recent change of -$126.00 thousand (-63.32%) on 01 September 2022.PSTI Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$338.00 K
+$58.00 K+20.71%
01 September 2022
Summary:
Pluristem Therapeutics TTM capital expenditures is currently $338.00 thousand, with the most recent change of +$58.00 thousand (+20.71%) on 01 September 2022.PSTI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -24.9% | +386.7% | +8.7% |
| 5 y5 years | +17.1% | +35.2% | +191.4% |
PSTI CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -93.5% | -96.3% | -92.2% |
Pluristem Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $73.00 K(-63.3%) | $338.00 K(+20.7%) |
| June 2022 | $280.00 K(-24.9%) | $199.00 K(+437.8%) | $280.00 K(+127.6%) |
| Mar 2022 | - | $37.00 K(+27.6%) | $123.00 K(-41.4%) |
| Dec 2021 | - | $29.00 K(+93.3%) | $210.00 K(-32.5%) |
| Sept 2021 | - | $15.00 K(-64.3%) | $311.00 K(-16.6%) |
| June 2021 | $373.00 K(+38.1%) | $42.00 K(-66.1%) | $373.00 K(-16.0%) |
| Mar 2021 | - | $124.00 K(-4.6%) | $444.00 K(+27.2%) |
| Dec 2020 | - | $130.00 K(+68.8%) | $349.00 K(+19.1%) |
| Sept 2020 | - | $77.00 K(-31.9%) | $293.00 K(+8.5%) |
| June 2020 | $270.00 K(+13.0%) | $113.00 K(+289.7%) | $270.00 K(+50.8%) |
| Mar 2020 | - | $29.00 K(-60.8%) | $179.00 K(+2.9%) |
| Dec 2019 | - | $74.00 K(+37.0%) | $174.00 K(+50.0%) |
| Sept 2019 | - | $54.00 K(+145.5%) | $116.00 K(-51.5%) |
| June 2019 | $239.00 K(-30.1%) | $22.00 K(-8.3%) | $239.00 K(-29.7%) |
| Mar 2019 | - | $24.00 K(+50.0%) | $340.00 K(-2.9%) |
| Dec 2018 | - | $16.00 K(-91.0%) | $350.00 K(-5.7%) |
| Sept 2018 | - | $177.00 K(+43.9%) | $371.00 K(+8.5%) |
| June 2018 | $342.00 K(-9.5%) | $123.00 K(+261.8%) | $342.00 K(+44.3%) |
| Mar 2018 | - | $34.00 K(-8.1%) | $237.00 K(-18.3%) |
| Dec 2017 | - | $37.00 K(-75.0%) | $290.00 K(-23.9%) |
| Sept 2017 | - | $148.00 K(+722.2%) | $381.00 K(+0.8%) |
| June 2017 | $378.00 K | $18.00 K(-79.3%) | $378.00 K(-34.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $87.00 K(-32.0%) | $575.00 K(+4.2%) |
| Dec 2016 | - | $128.00 K(-11.7%) | $552.00 K(-30.0%) |
| Sept 2016 | - | $145.00 K(-32.6%) | $789.00 K(-54.9%) |
| June 2016 | $1.75 M(+110.6%) | $215.00 K(+235.9%) | $1.75 M(+1.3%) |
| Mar 2016 | - | $64.00 K(-82.5%) | $1.73 M(-1.3%) |
| Dec 2015 | - | $365.00 K(-67.0%) | $1.75 M(+5.0%) |
| Sept 2015 | - | $1.11 M(+473.1%) | $1.67 M(+100.5%) |
| June 2015 | $831.00 K(-47.2%) | $193.00 K(+124.4%) | $831.00 K(+7.2%) |
| Mar 2015 | - | $86.00 K(-69.4%) | $775.00 K(-18.9%) |
| Dec 2014 | - | $281.00 K(+3.7%) | $956.00 K(-30.8%) |
| Sept 2014 | - | $271.00 K(+97.8%) | $1.38 M(-12.1%) |
| June 2014 | $1.57 M(-63.5%) | $137.00 K(-48.7%) | $1.57 M(-37.0%) |
| Mar 2014 | - | $267.00 K(-62.2%) | $2.50 M(+16.7%) |
| Dec 2013 | - | $707.00 K(+53.0%) | $2.14 M(-23.4%) |
| Sept 2013 | - | $462.00 K(-56.5%) | $2.79 M(-35.2%) |
| June 2013 | $4.31 M(+191.1%) | $1.06 M(-1267.0%) | $4.31 M(+26.2%) |
| Mar 2013 | - | -$91.00 K(-106.7%) | $3.41 M(-10.7%) |
| Dec 2012 | - | $1.36 M(-31.2%) | $3.82 M(+16.6%) |
| Sept 2012 | - | $1.98 M(+1084.4%) | $3.28 M(+121.6%) |
| June 2012 | $1.48 M | $167.00 K(-47.3%) | $1.48 M(+12.7%) |
| Mar 2012 | - | $317.00 K(-61.2%) | $1.31 M(+31.8%) |
| Dec 2011 | - | $817.00 K(+356.4%) | $996.00 K(+456.4%) |
| Sept 2011 | - | $179.00 K | $179.00 K |
FAQ
- What is Pluristem Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Pluristem Therapeutics?
- What is Pluristem Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Pluristem Therapeutics?
What is Pluristem Therapeutics annual capital expenditures?
The current annual CAPEX of PSTI is $280.00 K
What is the all time high annual CAPEX for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual capital expenditures is $4.31 M
What is Pluristem Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of PSTI is $73.00 K
What is the all time high quarterly CAPEX for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly capital expenditures is $1.98 M
What is Pluristem Therapeutics TTM capital expenditures?
The current TTM CAPEX of PSTI is $338.00 K
What is the all time high TTM CAPEX for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM capital expenditures is $4.31 M